SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-088149
Filing Date
2023-03-31
Accepted
2023-03-31 16:30:13
Documents
5
Effectiveness Date
2023-03-31

Document Format Files

Seq Description Document Type Size
1 S-8 d491027ds8.htm S-8 39829
2 EX-5.1 d491027dex51.htm EX-5.1 6150
3 EX-23.1 d491027dex231.htm EX-23.1 1511
4 EX-FILING FEES d491027dexfilingfees.htm EX-FILING FEES 14590
5 GRAPHIC g491027g0330021003490.jpg GRAPHIC 3252
  Complete submission text file 0001193125-23-088149.txt   67829
Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Filer) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-271036 | Film No.: 23788241
SIC: 2834 Pharmaceutical Preparations